Levodopa-induced dyskinesia: a historical review of Parkinson’s disease, dopamine, and modern advancements in research and treatment
- 17 January 2022
- journal article
- review article
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 269 (6), 2892-2909
- https://doi.org/10.1007/s00415-022-10963-w
Abstract
Over the past two decades, animal models of Parkinson’s disease (PD) have helped to determine the plausible underlying mechanism of levo-dihydroxyphenylalanine (l-DOPA)-induced dyskinesia following l-DOPA treatment. However, our understanding of the mechanisms related to this phenomenon remains incomplete. The purpose of this manuscript is to provide a comprehensive review of treatment protocols used for assessing the occurrence of l-DOPA-induced dyskinesia, l-DOPA absorption, distribution, drug/food interaction, and discuss current strategies and future directions. This review offers a historical perspective using l-DOPA in animal models of PD and the occurrence of l-DOPA-induced dyskinesia.Funding Information
- National Institute of Mental Health (R01-NS071122)
- National Institute on Drug Abuse (R01-DA026947)
- NIH Office of the Director (S10OD020026)
This publication has 95 references indexed in Scilit:
- Markers of Disease Severity Are Associated with Malnutrition in Parkinson's DiseasePLOS ONE, 2013
- Carbidopa/levodopa dose elevation and safety concerns in Parkinson's patients: a cross-sectional and cohort designBMJ Open, 2012
- Design of a Single AAV Vector for Coexpression of TH and GCH1 to Establish Continuous DOPA Synthesis in a Rat Model of Parkinson's DiseaseMolecular Therapy, 2012
- Dosage-dependent non-linear effect ofl-dopa on human motor cortex plasticityJournal Of Physiology-London, 2010
- Low‐protein and protein‐redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic reviewMovement Disorders, 2010
- Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video‐based analysisMovement Disorders, 2009
- Levodopa-Induced Dyskinesias in Parkinson’s Disease: Etiology, Impact on Quality of Life, and TreatmentsEuropean Neurology, 2008
- Dyskinesia after fetal cell transplantation for parkinsonism: A PET studyAnnals of Neurology, 2002
- L‐DOPA‐induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin‐ and glutamic acid decarboxylase mRNAEuropean Journal of Neuroscience, 1998
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983